Docusate (Na)

Docusate (Na) is a laxative, used in the treatment of constipation or fecal impaction. It acts primarily by increasing the penetration of fluid into faeces, also may affect other intestinal fluid secretions and probably acts both as stimulant and faecal softening agents. Docusate (Na) is also used as an adjunct for bowel evacuation prior to abdominal radiological procedures.

Brands
ABOLITIUM
Adult Dose
Neonatal
Paedriatic
Dose: 12.5 to 25 mg
Single Dose: 19 (18.75)
Frequency: 8 hourly
Route: 2 to 12 year of age
Instructions:
Characteristics
Diotyl sodium sulfosuccinate is the derivative of Docusate (Na). It is of Synthetic origin. . The Molecular Weight of Docusate (Na) is 444.56.
Contraindications
Docusate (Na) is contraindicated in conditions like Peptic ulcer,Ulcerative colitis,Appendicitis,Hemochromatosis,Haemolytic anaemia.
Effects
The severe or irreversible adverse effects of Docusate (Na), which give rise to further complications include Anorectal pain.The symptomatic adverse reactions produced by Docusate (Na) are more or less tolerable and if they become severe, they can be treated symptomatically, these include Nausea, Diarrhea, Abdominal cramps, Skin RashX.
Indications
Docusate (Na) is primarily indicated in conditions like Constipation.
Interactions
No data regarding the interactions of Docusate (Na) was found.
Interfrence
Risks
Drug should not be given to Pregnant Mothers.If prescribing authority justifies the benefits of the drug against the possible damages he/she should reevaluate them and consult the reference material and previous studies.
Storage
Oral Soln, Susp Store at room temperature. Do not Freeze. Tab, Caps Store at room temperature.
Warnings
Prolonged use should be avoided.
Back to List

Any information that appears on this website page is provided for the purpose of general information. This website has been compiled in good faith by HMIS.Online. However, no guarantee is made as to the completeness, validity or accuracy of the information it contains.